Projects
Sustainable COVID-19 Vaccination for Long-term Vaccine Immunity and Effectiveness KU Leuven
Despite the rapid development of various SARS-CoV-2 vaccines, the control of the pandemic is hampered by the constant emergence of SARS-CoV-2 variants escaping vaccine-induced immunity and the waning of immunity. SOLVE will tackle these challenges by deciphering the mechanisms of induction of long-lasting immunity and evaluating new vaccine platforms. To achieve this goal, an integrated plan has been developed including six pillars: 1) ...
COVID19 – TriVoice PLUS – Astra-Zeneca derde dosis, Vaccination against Covid-19 in cancer: booster shot BNT161b2 vaccine after full vaccination with ChAdOx1-S vaccine (Tri-VOICE plus). University of Antwerp
Consortium Agreement concerning the EDCD-prject: "VACCINE PREVENTABLE DISEASES MODELLING IN THE EUROPEAN UNION AND EEA/EFTA COUNTRIES: FORECASTING TNHE EFFECT OF INTRODUCING A NEW VACCINE IN A NATIONAL/REGIONAL PROGRAM" Hasselt University
Next Steps in HBV Vaccine Research: Novel Small Animal Models for HBV Infection and Innovative Microneedle Patch-Based Vaccine Delivery Methods KU Leuven
More than 300 million people worldwide suffer from chronic hepatitis B. Current standard-of-care is based on the administration of suppressive antiviral therapies with the intent of decreasing viral titres and thus delaying any long-term effects of the disease. However, full clearance is rarely achieved and long-term exposure to the hepatitis B virus will imminently lead to detrimental effects on the liver, eventually resulting into the ...
Investigation to reveal the immune reaction upon COVID vaccination in the Belgian cancer population: COVID protection and vaccine safety (REAL-V). University of Antwerp
Investigation to reveal the immunerReaction upon COVID-vaccination in the Belgian cancer population: COVID protection and vaccine safety (REAL-V). University of Antwerp
Production of immunogenic tumor lysate loaded mesoporous silica nanoparticles as anti-cancer vaccine KU Leuven
With cancer being a leading cause of mortality, immunotherapy is emerging as an innovative procedure to control the disease. It is a fast evolving complex field aiming to stimulate components of the immune system against tumor cells. One of these approaches is active specific immunotherapy based on the injection of autologous mature dendritic cells loaded with autologous tumor lysate. Proof-of-principle studies have shown that these vaccines ...